ArticleFrontiers in global women's health2026
Impact of breastfeeding on serological recovery and metabolic homeostasis in postpartum women with celiac disease: a longitudinal study.
Article in Frontiers in global women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objetives: Pregnancy and the subsequent postpartum period represent a physiological challenge for women with Celiac Disease (CD), often characterized by nutritional depletion and hormonal fluctuations. While the benefits of breastfeeding for the infant are well-established, its impact on maternal CD clinical evolution remains under-researched. Objective: To evaluate the influence of exclusive breastfeeding (EBF) on the normalization of serological markers, iron stores, and bone mineral homeostasis in women with CD. Methods: A prospective longitudinal study was conducted with 255 CD women in Central Spain. Participants were followed from the third trimester of pregnancy (T0) to 12 months postpartum (T2). Parameters included anti-tissue transglutaminase (tTG-IgA) titers, serum ferritin, and bone mineral density ( Results: At 12 months, the EBF group ( Conclusions: Breastfeeding acts as a beneficial physiological modulator in the celiac mother, accelerating the clearance kinetics of serological markers and promoting a more efficient recovery of metabolic and nutritional homeostasis during the postpartum transition.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.